FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4776511000001107: Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26545901000001115 Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
54774201000001113 Lidocaine 2% and Chlorhexidine gel (AstraZeneca UK Ltd) 15 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml Is a Lidocaine 2% / Chlorhexidine 0.05% gel 15 ml true Inferred relationship Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml Is pack of Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) false Inferred relationship Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml Has active ingredient Lidocaine hydrochloride false Inferred relationship Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml Has active ingredient Chlorhexidine gluconate false Inferred relationship Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml Legal category Pharmacy medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml Has AMP Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) true Inferred relationship Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml Has specific active ingredient Lidocaine hydrochloride true Inferred relationship Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml Has specific active ingredient Chlorhexidine gluconate true Inferred relationship Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start